Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study )

NCT02244801 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: darTreg infusion

Sponsor

University of California, San Francisco

Collaborators

[object Object]